A missed dose, modelled: what happens to retatrutide concentrations over the following fortnight
An accumulation model, drawn from published parameters, with its assumptions stated.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 4 of 4 of this archive, newest first.
An accumulation model, drawn from published parameters, with its assumptions stated.
Head-to-head data exists for some of these comparisons and not for others. This piece says which.
Selectivity, potency and efficacy are three different measurements. The trade routinely reports none of them.
Head-to-head data exists for some of these comparisons and not for others. This piece says which.
The molecular engineering that turned a peptide with a two-minute half-life into a once-weekly drug.